Welcome to our dedicated page for Mountain Vy Md news (Ticker: MVMDF), a resource for investors and traders seeking the latest updates and insights on Mountain Vy Md stock.
Mountain Valley MD Holdings Inc. reports developments across commercialization of its patented Quicksome™ and Quicksol™ formulation technologies, its licensed Agrarius™ agricultural plant signaling product, and related branded nutraceutical initiatives. News about MVMDF commonly covers nutraceutical product formats, agricultural product evaluations, regional distribution and regulatory work, and applications for husbandry animals and aquatic species.
Company updates also include capital actions such as private placements and shares-for-debt transactions, stock option grants, advisor and board appointments, and shareholder or governance matters tied to its public-company status.
Mountain Valley MD Holdings Inc. (MVMD) provided a business update on its three core lines: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. Key developments include:
1. Nutraceuticals: Completed setup for Quicksome™ technology production. Launched Eons Deeper Sleep product with Circadian Wellness. Internal testing showed improved sleep metrics.
2. Agriculture: Acquired exclusive license for Agrarius agricultural technology in the Americas and Caribbean. Obtained product registration in EU, 44 US states, Canada, and Brazil. Launched Performance Guarantee Program for North American farmers.
3. Husbandry/Aquatic: Developed Soluvec™ 1% (solubilized Ivermectin) for animal applications. Licensed to a partner in Bangladesh for fish feed coating, with shipments planned for Q3 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTCQB: MVMDF) has granted 3,220,000 stock options to its directors, officers, and consultants as part of its Stock Option Plan. The options will vest over a period of time, with 20% available immediately, 30% after six months, and 50% after one year. These options are part of MVMD’s strategy to align team efforts with business goals and enhance shareholder value. The company focuses on commercializing key technologies, including Quicksome™ and Quicksol™ formulations, aimed at improving health and agricultural yields.